首页 | 本学科首页   官方微博 | 高级检索  
检索        

59例男性肿瘤患者放化疗前勃起功能状况评价
引用本文:张建文,符立平,文恩,刘涛.59例男性肿瘤患者放化疗前勃起功能状况评价[J].重庆医学,2012,41(25):2607-2608,2610.
作者姓名:张建文  符立平  文恩  刘涛
作者单位:泸州医学院附属医院肿瘤科,四川泸州,646000
摘    要:目的分析男性肿瘤患者放化疗前的勃起功能,以及与肿瘤类型和年龄的关系。方法对59例初次接受放化疗的男性肿瘤患者,以国际勃起功能指数-5(IIEF-5)为评价指标,采用问卷调查的方式,由患者自行填写,总结IIEF-5的得分。结果 59例男性患者中,IIEF-5评分最高为25分,最低为0分,其中大于或等于21分25例,12~20分27例,8~11分4例,≤7分3例。无勃起功能障碍(ED)的为42.37%(25/59),有ED的为57.63%(34/59);其中,轻度ED 45.76%(27/59),中度ED 6.78%(4/59),重度ED 5.08%(3/59)。不同类型肿瘤间IIEF-5评分不同,肺癌和精原细胞瘤的IIEF-5评分最高,其次为结肠癌和胃癌,鼻咽癌和其他肿瘤的IIEF-5评分最低,分别为(20.40±2.24)、(20.00±2.55)、(18.56±4.88)、(18.33±6.43)、(16.33±7.30)、(17.67±2.52)分,不同类型肿瘤患者IIEF-5评分比较,差异无统计学意义(P>0.05)。不同年龄组间IIEF-5评分不同,30~40岁组评分最高,其次为>50~60岁组,>40~50岁组评分最低,分别为(19.17±3.92)、(17.67±7.01)、(15.92±8.31)分,但差异均无统计学意义(P>0.05)。结论男性肿瘤患者初次接受放化疗前存在ED,以轻度ED为主。应加强对男性肿瘤患者的性知识宣传,有利于提高患者的生存质量。

关 键 词:肿瘤  阴茎勃起  化学疗法  放射疗法  国际勃起功能指数-5

Evaluation of erectile function before radiochemotherapy in 59 male tumor patients
Zhang Jianwen , Fu Liping , Wen En , Liu Tao.Evaluation of erectile function before radiochemotherapy in 59 male tumor patients[J].Chongqing Medical Journal,2012,41(25):2607-2608,2610.
Authors:Zhang Jianwen  Fu Liping  Wen En  Liu Tao
Institution:(Department of Oncology,Affiliated Hospital,Luzhou Medical College,Luzhou,Sichuan 64600,China)
Abstract:Objective To analyze the status of the erectile function(EF) before radiochemotherapy and its relationship with tumor type and age in male tumor patients.Methods By using the International Index of Erectile Function(IIEF-5) as the evaluation indicator,59 male tumor patients with initial radiochemotherapy were investigated with filling in questionnaire by patient-self.The IIEF-5 scores were summarized.Results Among 59 cases,the maximum IIEF-5 score was 25 and the minimum IIEF-5 score was 0.25 cases were ≥ 21,27 cases were 20-12,4 cases were 11-8 and 3 cases were ≤7.42.37%(25/59) had no erectile dysfunction(ED),whereas 57.63%(34/59) had ED.Mild ED was 79.41%(27/34),moderate ED was 11.76%(4/34) and severe ED was 8.82%(3/34).There were different IIEF-5 scores for different types of tumors,the maximum IIEF-5 scores were in lung cancer and spermatocytoma,followed by colon carcinoma and gastric cancer,the minimum IIEF-5 scores were nasopharyngeal carcinoma and other tumors,IIEF-5 scores werein turn 20.40±2.24,20.00±2.55,18.56±4.88,18.33±6.43,16.33±7.30 and 17.67±2.52,respectively,but the difference had no statistical significance(P>0.05).There was different IIEF-5 scores for different ages,the maximum IIEF-5 scores were 30-40 years group,followed by >50-60 years group,the minimum IIEF-5 scores were >40-50 years group,the IIEF-5 score were in turn 19.17±3.92,17.67±7.01,15.92±8.31,respectively.But difference had no statistical significance(P>0.05).Conclusion ED exists in male tumor patients before radiochemotherapy,which is mainly mild ED.It is very essential to enhance propaganda and education of sexual knowledge for benefiting to raise the quality of life for male tumor patients.
Keywords:neoplasms  penile erection  chemotherapy  radiotherapy  international index of erectile function-5  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号